150 related articles for article (PubMed ID: 12481382)
1. In vitro antimicrobial interactions of arthemeter with some 4-quinolones.
Esimone CO; Adikwu MU; Nwafor SV; Okoli CO; Ndu OO; Nwoke OI
Boll Chim Farm; 2002; 141(5):385-8. PubMed ID: 12481382
[TBL] [Abstract][Full Text] [Related]
2. Rufloxacin (MF-934): in vitro and in vivo antibacterial activity.
Ravizzola G; Pinsi G; Pirali F; Colombrita D; Foresti I; Peroni L; Turano A
Drugs Exp Clin Res; 1989; 15(1):11-5. PubMed ID: 2743869
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of pefloxacin compared to that of quinolones and other antimicrobial agents.
Neu HC; Chin NX; Labthavikul P; Saha G
Chemioterapia; 1984 Aug; 3(4):235-41. PubMed ID: 6241847
[TBL] [Abstract][Full Text] [Related]
4. In vitro antibacterial activity of enrofloxacin and ciprofloxacin in combination against Escherichia coli and staphylococcal clinical isolates from dogs.
Lautzenhiser SJ; Fialkowski JP; Bjorling D; Rosin E
Res Vet Sci; 2001 Jun; 70(3):239-41. PubMed ID: 11676620
[TBL] [Abstract][Full Text] [Related]
5. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
Cetinkaya E; Coban AY; Durupinar B
Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of pefloxacin activity against recent clinical isolates.
Lembo M; Covelli B; Nani E; Lavitola A
J Chemother; 1991 Jan; 3 Suppl 1():51-3. PubMed ID: 12041785
[TBL] [Abstract][Full Text] [Related]
7. The frequency of in vitro resistance to fluoroquinolones among clinical isolates of Escherichia coli.
Poiată A; Bădicuţ I; Grigore L; Buiuc D
Roum Arch Microbiol Immunol; 2000; 59(1-2):63-9. PubMed ID: 11845477
[TBL] [Abstract][Full Text] [Related]
8. Influence of temperature on mutational resistance to 4-quinolones.
Parte AC; Smith JT
Arzneimittelforschung; 1996 Apr; 46(4):429-32. PubMed ID: 8740093
[TBL] [Abstract][Full Text] [Related]
9. [Synthesis and antibacterial activity of 1-substituted benzyl quinolone acid derivatives].
Zhou SQ; Zhu CQ; Wu GP; Peng SX
Yao Xue Xue Bao; 1990; 25(9):670-6. PubMed ID: 2128731
[TBL] [Abstract][Full Text] [Related]
10. Comparative pharmacodynamics of the new fluoroquinolone ABT492 and ciprofloxacin with Escherichia coli and Pseudomonas aeruginosa in an in vitro dynamic model.
Zinner SH; Vostrov SN; Alferova IV; Lubenko IY; Portnoy YA; Firsov AA
Int J Antimicrob Agents; 2004 Aug; 24(2):173-7. PubMed ID: 15288317
[TBL] [Abstract][Full Text] [Related]
11. Postantibiotic effect of ciprofloxacin compared with that of five other quinolones.
Minguez F; Ramos C; Barrientos S; Loscos A; Prieto J
Chemotherapy; 1991; 37(6):420-5. PubMed ID: 1760941
[TBL] [Abstract][Full Text] [Related]
12. In vitro antibacterial activity of E-3604, a new 6-fluoroquinolone, on clinical isolates.
Xicota MA; Coll R; Esteve M; Moros M; Parés J
Drugs Exp Clin Res; 1987; 13(3):133-6. PubMed ID: 3622242
[TBL] [Abstract][Full Text] [Related]
13. [Study of quinolones resistance in Escherichia coli, Staphylococcus aureus and Pseudomonas areuginosa].
Feng P; Yu R; Xia P; Lü X; Zhu S
Hua Xi Yi Ke Da Xue Xue Bao; 2001 Dec; 32(4):501-4. PubMed ID: 12528531
[TBL] [Abstract][Full Text] [Related]
14. 4-Quinolone bactericidal mechanisms.
Howard BM; Pinney RJ; Smith JT
Arzneimittelforschung; 1993 Oct; 43(10):1125-9. PubMed ID: 7505585
[TBL] [Abstract][Full Text] [Related]
15. [Comparative in vitro antistaphylococcal effect of norfloxacin and pefloxacin on 312 hospital strains].
Ronco E; Pilliot J
Pathol Biol (Paris); 1985 May; 33(5):381-4. PubMed ID: 3162139
[TBL] [Abstract][Full Text] [Related]
16. [Studies on pyridonecarboxylic acids as antibacterial agents. XII. Synthesis and antibacterial activity of 6-chloro-1-cyclopropyl-7-(1-piperazinyl)-1, 4-dihydro-4-oxo-quinoline-3-carboxylic acid and analogues].
Li XH; Tian ZM; Miao H; Yu LX; Guo HY
Yao Xue Xue Bao; 1997 Nov; 32(11):844-51. PubMed ID: 11596203
[TBL] [Abstract][Full Text] [Related]
17. Post-antibiotic effect of three quinolones against gram negative isolates from urine.
Alados JC; Gutierrez J; Garcia F; Liebana J; Piedrola G
Med Lab Sci; 1990 Oct; 47(4):272-7. PubMed ID: 2283929
[TBL] [Abstract][Full Text] [Related]
18. [Comparative activities in vitro of 4 quinolones (nalidixic acid, pefloxacin, norfloxacin, ofloxacin) on 13 bacterial species].
Rahal K
Arch Inst Pasteur Alger; 1992; 58():41-84. PubMed ID: 1309146
[TBL] [Abstract][Full Text] [Related]
19. Comparative in-vitro activities of commonly available quinolones and other antibiotics on bacterial isolates in Ibadan, Nigeria.
Oni AA; Bakare RA; Arowojolu AO; Kehinde Toki RA; Fasina NA
Afr J Med Med Sci; 2001; 30(1-2):35-7. PubMed ID: 14510147
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of pefloxacin.
Husson MO; Izard D; Bouillet L; Leclerc H
Drugs Exp Clin Res; 1986; 12(4):313-7. PubMed ID: 3522154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]